Table 1.
IHD group (n = 100) | EHD group (n = 50) | |
1. Age (years) (mean ± SD) | 63 ± 11 | 63 ± 9 |
2. Male(M) to female(F) ratio | 3/1 (75M/25F patients) | 3/1 (38M/12F patients) |
3. Preoperative lab values (mean ± SD) | ||
a. platelets × 1012 (cell/L) | 210.5 ± 91 | 215 ± 88 |
b. prothrombin time (INR) | 0.98 ± 0.09 | 0.91 ± 0.08 |
c. bilirubin (μmol/L) | 9.2 ± 4.1 | 9.5 ± 4.2 |
d. AST (U/L) | 35 ± 15 | 36 ± 14 |
e. albumin (g/dl) | 4.8 ± 0.7 | 4.6 ± 0.8 |
4. Indication for resection | ||
a. hepatocellular carcinoma (70) | 46 (46%) | 24 (48%) |
b. metastatic carcinoma (60) | 45 (45%) | 15 (30%) |
c. benign lesions (20) | 9 (9%) | 11 (22%) |